Partior, the global unified ledger market infrastructure for clearing and settlement, has announced the successful raise of $60 million in funding. The company, founded in 2021, has gained significant traction for its innovative approach to optimizing liquidity access and transforming global money movement. The funding will be used to further enhance Partior's cutting-edge technology and expand its reach in addressing industry inefficiencies such as settlement delays and high operating costs. With shareholders including Temasek, DBS, J.P. Morgan, and Standard Chartered, Partior is well-positioned to revolutionize the financial landscape by offering real-time, cross-border multi-currency payments, PvP, DvP settlements, and trade finance functions. This funding milestone solidifies Partior's commitment to revolutionizing the financial industry and providing seamless solutions for financial institutions and their customers worldwide.
Partior Secures USD 60 Million in Series B Funding to Revolutionize Global Money Movement
Recently funded 路 $60.0M Series bBlockchain/Technology
Get the full Partior company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
